C12N 2795/12043
Viral genome or elements thereof as genetic vector
Official title: viral genome or elements thereof as genetic vector
C12N2795/12043 (Viral genome or elements thereof as genetic vector) appears on 5 US grants and 7 published applications in this corpus.
Search patents in C12N- Granted patents
- 5
- Published applications
- 7
- Assignees
- 4
- Inventors
- 12
- Latest grant
- 9 Jun 2020
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2004 | 0 | 1 |
| 2005 | 0 | 0 |
| 2006 | 1 | 2 |
| 2007 | 0 | 0 |
| 2008 | 1 | 0 |
| 2009 | 1 | 1 |
| 2010 | 1 | 0 |
| 2011 | 0 | 1 |
| 2012 | 0 | 0 |
| 2013 | 0 | 0 |
| 2014 | 0 | 0 |
| 2015 | 0 | 1 |
| 2016 | 0 | 0 |
| 2017 | 0 | 0 |
| 2018 | 0 | 0 |
| 2019 | 0 | 0 |
| 2020 | 1 | 0 |
| 2021 | 0 | 0 |
| 2022 | 0 | 0 |
| 2023 | 0 | 1 |
By publication year.
Recent patents
- Bacteriophages expressing antimicrobial peptides and uses thereof9 Jun 2020US 10,676,721 B2Massachusetts Institute of Technology
- Recombinant double stranded RNA nucleocapsid and use of the same14 Dec 2010US 7,850,958 B2University of Maryland Biotechnology Institute
- Recombinant double-stranded RNA phage, and use of the same4 Aug 2009US 7,569,219 B2University of Maryland Biotechnology Institute
- Recombinant double-stranded RNA phages and uses thereof5 Aug 2008US 7,407,790 B2University of Maryland Biotechnology Institute
- Recombinant double-stranded RNA phage, and use of the same28 Mar 2006US 7,018,835 B2
- Fusobacterium bacteriophage and uses thereof7 Dec 2023US 2023/0390349 A1Biomx Ltd.
- Bacteriophages expressing antimicrobial peptides and uses thereof19 Feb 2015US 2015/0050717 A1Massachusetts Institute of Technology
- Recombinant Double-Stranded RNA Phage, and Use of the Same3 Mar 2011US 2011/0052628 A1
- Recombinant Double-Stranded RNA Phage, and Use of the Same10 Dec 2009US 2009/0305398 A1University of Maryland Biotechnology Institute
- Recombinant double-stranded RNA phage, and use of the same30 Nov 2006US 2006/0269570 A1University of Maryland Biotechnology Institute
Most cited
By later US patents
- Recombinant double-stranded RNA phages and uses thereof5US 7,407,790 B2University of Maryland Biotechnology Institute · 2008
- Recombinant double-stranded RNA phage, and use of the same4US 7,018,835 B22006
- Recombinant double-stranded RNA phage, and use of the same3US 7,569,219 B2University of Maryland Biotechnology Institute · 2009
- Recombinant double stranded RNA nucleocapsid and use of the same3US 7,850,958 B2University of Maryland Biotechnology Institute · 2010
- Bacteriophages expressing antimicrobial peptides and uses thereof1US 10,676,721 B2Massachusetts Institute of Technology · 2020